Clinical trials
Cerebral Palsy trials in Pakistan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
176 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 5 |
| 2019 | 6 |
| 2020 | 4 |
| 2021 | 20 |
| 2022 | 19 |
| 2023 | 39 |
| 2024 | 40 |
| 2025 | 18 |
| 2026 | 23 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 115 |
| Recruiting | 25 |
| Unknown status | 21 |
| Active, not recruiting | 8 |
| Not yet recruiting | 6 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Riphah International University | 116 |
| University of Lahore | 15 |
| Ibadat International University, Islamabad | 7 |
| Superior University | 6 |
| Foundation University Islamabad | 4 |
| Lahore University of Biological and Applied Sciences | 4 |
| Ziauddin University | 3 |
| Dow University of Health Sciences | 2 |
| Health Education Research Foundation (HERF) | 2 |
| Isra University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cerebral Palsy | 176 |
| Muscle Spasticity | 18 |
| Hemiplegia | 4 |
| Constipation | 3 |
| Gait Disorders, Neurologic | 3 |
| Communication Disorders | 1 |
| Down Syndrome | 1 |
| Dysarthria | 1 |
| Epilepsy | 1 |
| Feeding and Eating Disorders | 1 |
Trials
Showing 51 to 75 of 176. Each trial links to its page on Pharma Observatory.
76 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.